Movers roundup: Human Genome Sciences, Forest Labs

Recs

0

Special Offer!

Jan 12, Motley Fool Pro will accept new members for 10 days only. Your spot is reserved! To learn more, click below.

Among the stock activity stories for Wednesday, Sept. 3, from AP Financial News:

ROCKVILLE, Md. (AP) _ Shares of the Human Genome Sciences Inc. sank Wednesday after the biotech company reported what was seen as a disappointing result from the midstage trial of a cancer treatment.

NEW YORK (AP) _ Shares of Forest Laboratories Inc. fell to a seven-year low Wednesday following disappointing results from two late-stage trials of Forest's drug candidate aclidinium bromide.

NEW YORK (AP) _ Shares of Neurocrine Biosciences Inc. rose Wednesday after the company said its drug candidate elagolix met all its goals in a midstage safety trial, causing little bone density loss and reducing pain from endometriosis.

NEW YORK (AP) _ Shares of Green Mountain Coffee Roasters Inc. fell Wednesday after a Stifel Nicolaus analyst downgraded the stock, saying costs are likely to rise and growth in single-cup brewers may not meet expectations.

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

TD AMERITRADE
more info
ShareBuilder
more info
Power E*Trade

more info
Scottrade
more info
Fool Disclosure

DocumentId: 720040, ~/articles/articlehandler.aspx, 1/8/2009 1:02:09 AM

Sign up for FREE Motley Fool site access to keep reading:

“Movers roundup: Human Genome Sciences, Forest Labs”

Signing up allows you to comment on articles and on the discussion boards.

It's completely FREE and will take only 10 seconds.

Privacy / Legal Information

We will use your email address only to keep you informed about updates to our web site and about other products and services that we think might interest you. The Motley Fool respects your privacy. Please read our Privacy Statement

.

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

What Fools Are Saying

Most Recent

Most Recommended

Jan 7 at 4:08 PM

Market Summary

DJIA 8,769.70 -245.40 -2.72%
S&P 500 906.65 -28.05 -3.00%
NASD 1,599.06 -53.32 -3.23%
Sponsored by:

Related Tickers

Forest Laboratories, Inc.

CAPS Rating 4/5 Stars

$25.01

-0.38 (-1.50%)

Outperform336

Underperform27

Rate This Stock